Perioperative Mechanism of Acute Kidney Injury in Cardiovascular Surgery
Sponsor
The First Affiliated Hospital of Anhui Medical University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03557047
Collaborator
(none)
50
1
41.8
1.2
Study Details
Study Description
Brief Summary
Continuous observation of acute renal injury after cardiac surgery, at the same time retention of blood samples, to test indicators,and to select the research route from the clinical actual test results .
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
50 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Preliminary Study on the Pathogenesis of Acute Kidney Injury After Cardiac Surgery
Actual Study Start Date
:
Mar 8, 2018
Anticipated Primary Completion Date
:
Mar 1, 2021
Anticipated Study Completion Date
:
Sep 1, 2021
Outcome Measures
Primary Outcome Measures
- Incidence of acute renal injury after cardiac surgery [48 hours]
The standard of acute renal injury is based on the KDIGO
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Adult patients undergoing selective cardiac surgery, aged between 18 and 80.
Exclusion Criteria:
- Normal range of creatinine before operation
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The First Affiliated Hospital of Anhui Medical University | Hefei | Anhui | China | 230022 |
Sponsors and Collaborators
- The First Affiliated Hospital of Anhui Medical University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
The First Affiliated Hospital of Anhui Medical University
ClinicalTrials.gov Identifier:
NCT03557047
Other Study ID Numbers:
- PJ2018-03-10
First Posted:
Jun 14, 2018
Last Update Posted:
Jul 3, 2018
Last Verified:
Mar 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: